STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

Advocacy

We are the voice of the home and specialty infusion
community and the patients we serve

NHIA represents and advances the interests of organizations that provide infusion and alternate site pharmacy services and products to the entire spectrum of home-based patients. In doing so, we consider the provision of cost-effective and high quality medical care to patients undergoing infusion therapy to be of the utmost importance.

As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting the home and specialty infusion field and how to use your voice to advance the industry.

Latest Advocacy News

NHIA Releases Comments on California Senate Bill 958

NHIA submitted comments on California SB 958, the Medication and Patient Safety Act of 2022, supporting amendments to the proposed legislation that allow for infused medications to be administered in the enrollee’s home when the physician and patient determine it is in the patient’s best interest and weighing in on various other aspects of the bill.

Read More »

NHIA Submits Comments on DIR Proposed Rule

NHIA submitted comments on a CMS proposed rule: Medicare and Medicaid Programs; CY 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs, which would alter the way pharmacy price concessions, including direct and indirect remuneration (DIR fees), are calculated by pharmacy benefit managers (PBMs).

Read More »

PITCH In Campaign

Donate to the PITCH In Campaign to support NHIA’s Grassroots Efforts

Litigation

Read more >>

Sign up for NHIA’s
Open Access Email
list

Sign up now to get advocacy
updates and alerts >>